JPMorgan initiates Odyssey Therapeutics stock rating at Overweight

Markets Investing.com By Investing.com 02 Jun 2026 05:41 1 min read

JPMorgan initiates Odyssey Therapeutics stock rating at Overweight

JPMorgan initiates Odyssey Therapeutics stock rating at Overweight

JPMorgan initiates Odyssey Therapeutics stock rating at Overweight

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.